RxDoctor Payments DataLook up a doctor →

ERWINAZE: payments to doctors

Payments that named ERWINAZE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$103K
Providers
77
Transactions
87
Average per transaction
$1,184

The per-transaction average — $1,184 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 77 providers the average total is $1,337, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Jazz Pharmaceuticals Inc.$87,66685.1%
JAZZ Pharmaceuticals Inc.$15,31714.9%
← All drugs & devices